Breakthrough in diabetes research: Cells produce insulin upon artemisinin treatment supriya kashyap kashyap2 Dec 2016 2:17 PM ISTIt promises to be a simple and elegant strategy to heal diabetes type 1: Replacing the destroyed beta-cells in the bodies of patients with newly...
This drug reduces type 2 diabetes by 80 percent supriya kashyap kashyap3 March 2017 11:36 AM ISTWashington : A weight loss drug has reduced the risk of type 2 diabetes by 80 per cent compared to placebo.The drug, which increases the amount of...
Tight Control of Diabetes more harmful: Devote Trial supriya kashyap kashyap18 Sept 2017 3:56 PM ISTNovo Nordisk recently announced new analyses from the DEVOTE trial showing that people with type 2 diabetes who experience severe hypoglycaemia (low...
Semaglutide -New once-weekly option for Type 2 diabetes approved Dr. Kamal Kant Kohli Kohli5 Dec 2017 7:25 PM ISTEndocrinologic and Metabolic Drugs Advisory Committee (EMDAC) of the U.S. Food and Drug Administration (FDA) approved once-weekly semaglutide to...
Semaglutide causes greater reductions in HbA1c, body weight compared with Dulaglutide Medical Dialogues Bureau3 Feb 2018 8:30 PM ISTAccording to results of 40-week SUSTAIN 7 trial Published in The Lancet Diabetes & Endocrinology, patients of type 2 diabetes treated with...
Oral semaglutide better than empagliflozin in improving HbA1c -PIONEER 2 trial Vinay Singh singh3 Jun 2018 8:25 PM ISTTreatment with oral semaglutide 14mg led to a statistically significant improvement in hemoglobin A1c (HbA1c) levels and weight loss in adults with...
Blood sugar control: Insulin degludec better than insulin glargine, reveal results from CONCLUDE trial Medha Baranwal Baranwal19 Sept 2019 8:20 PM ISTLow blood sugar or hypoglycemia is the most common side effect of insulin glargine -- used for the management of diabetes. Now, a recent study seemed...
